Immune Responsiveness in Patients With Choroidal Malignant Melanoma
American Journal of Ophthalmology, ISSN: 0002-9394, Vol: 87, Issue: 2, Page: 215-220
1979
- 8Citations
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef8
- Captures6
- Readers6
Article Description
We studied selective in vivo and in vitro immunologic factors of 25 patients with choroidal malignant melanoma. Immune profile factors did not show consistent differences between patients with melanoma and an age-matched control population. The studies were also non-contributory in delineating variations in immunocompetence with respect to melanoma cell types. Serial immune profiles failed to identify a change when clinical evidence of metastasis developed. When tested as a group, patients with melanoma in whom metastatic disease developed during the study showed significant depression of initial mitogen-induced lymphocyte blastogenesis. This depression was noted in advance of clinically recognized metastatic disease. This group had a wide range of responses that overlapped those of control patients, thus making the usefulness of these testing factors questionable for individual prognosis or for clinical monitoring. © 1979.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0002939479901466; http://dx.doi.org/10.1016/0002-9394(79)90146-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0018390942&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/312019; https://linkinghub.elsevier.com/retrieve/pii/0002939479901466; http://dx.doi.org/10.1016/0002-9394%2879%2990146-6; https://dx.doi.org/10.1016/0002-9394%2879%2990146-6
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know